Benchmarking Glycoproteomics Software Using Diagnostic Ion Based Post-Validation for Glycopeptide Identification
Journal of Proteome Research · 06.11.2026 · 25 (11) · 5846-5861
DOI: 10.1021/acs.jproteome.6c00345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 01.10.2026. Verfasst von Hiroaki Sakaue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Indust…. Hauptthemen laut MEDLINE: Glycopeptides, Software, Proteomics. Die Arbeit nennt 49 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Advancements in glycoproteomics software have improved glycopeptide identification. However, algorithmic differences cause discrepancies in glycopeptide identifications even when identical data sets are used. We compared five state-of-the-art glycoproteomics software programs (Byonic, MSFragger-Glyco, pGlyco3, Glyco-Decipher, and GRable), investigating their ability to identify rare NeuGc- and KDN-containing glycopeptides from BJAB-K20 cells, which lack UDP-N-acetylglucosamine 2-epimerase, the rate-limiting enzyme for sialic acid synthesis. Approximately one-third of the identified glycopeptides were unique to individual tools. Byonic identified the most glycopeptides, whereas Glyco-Decipher and GRable identified complex, highly branched glycans. NeuGc- and KDN-containing glycopeptides were identified by specific programs, highlighting their ability to handle rare glycan structures. To assess the reliability of these identifications, we reanalyzed the MS/MS spectra and stratified all identifications retained under the software-specific criteria based on spectral evidence from diagnostic oxonium ions and Y0/Y1 or b/y ions. Although most were robustly supported, some relied on weaker evidence and warranted cautious interpretation. Leveraging the capabilities of each program enabled comprehensive, reliable analysis of glycopeptides with rare glycan structures. Combining software programs with complementary strengths and systematic postvalidation using diagnostic oxonium ions and Y0/Y1 ions provides an independent spectrum-level confidence assessment beyond conventional FDR-based filtering, improving the reliability and depth of glycopeptide identification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki305-8565, Japan.
- Department of Anatomy, Showa Medical University School of Medicine, Shinagawa-ku, Tokyo142-8555, Japan.
- Department of Experimental Pathology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki305-8575, Japan.
- Institute for Glyco-Core Research (iGCORE), Nagoya University, Nagoya, Aichi464-8601, Japan.
ORCID-Profile: Hiroaki Sakaue, Chiaki Nagai-Okatani, Atsushi Kuno
Förderung
- JSPS KAKENHI
Zitieren
APA
Sakaue, H., Kawanishi, K., Tomioka, A., Nagai-Okatani, C., Kaji, H., & Kuno, A. (2026). Benchmarking Glycoproteomics Software Using Diagnostic Ion Based Post-Validation for Glycopeptide Identification. Journal of Proteome Research, 25(11), 5846-5861. https://doi.org/10.1021/acs.jproteome.6c00345
Vancouver
Sakaue H, Kawanishi K, Tomioka A, Nagai-Okatani C, Kaji H, Kuno A. Benchmarking Glycoproteomics Software Using Diagnostic Ion Based Post-Validation for Glycopeptide Identification. Journal of Proteome Research. 2026;25(11):5846-5861. doi:10.1021/acs.jproteome.6c00345
BibTeX
@article{Sakaue2026,
author = {Sakaue, Hiroaki and Kawanishi, Kunio and Tomioka, Azusa and Nagai-Okatani, Chiaki and Kaji, Hiroyuki and Kuno, Atsushi},
title = {Benchmarking Glycoproteomics Software Using Diagnostic Ion Based Post-Validation for Glycopeptide Identification},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {11},
pages = {5846--5861},
doi = {10.1021/acs.jproteome.6c00345}
}
EUVIMED